Download May 16-20, 2016 - Western University

DIVISION OF CARDIOLOGY - SUMMARY OF WEEKLY ROUNDS SCHEDULE
MONDAY, MAY 16 to FRIDAY, MAY 20, 2016
Monday, May 16:
8:00-9:00
Aud B UH,
B2-116 VH &
B2-075
St. Joseph’s
OTN Event #
53872641
12:00
Sunningdale
Country Club,
465 Sunningdale
Road, London
519.660.8063
12:00-1:30
B6-115 UH
Cardiovascular Grand Rounds Presenter: R. McKelvie
Title of Presentation: Heart Failure Management in Ontario: How to Make it Better?
Learning Objectives:
1. Understand the impact of heart failure in the community.
2. Understand the gaps in heart failure management.
3. Propose a plan to improve heart failure management in Ontario.
16th Annual Cardiovascular Residents’ Research Day Attendance open to Residents, Fellows and
Division Members. RSVP to Charlene Grass if attending (Ext 33830 or email [email protected])
Chair: G. Pickering Honorary Judges: P. Leong-Sit, N. Suskin & J. Roberts
Keynote Speaker and Guest Judge: R. McKelvie
Title of Keynote Address: From UWO to Western: The life of a clinical and sometimes academic
cardiologist
Adult Congenital Cardiac Surgery Rounds - Videoconference from Toronto
Case-based presentation and discussion
OTN Event #
50897706
Tuesday, May 17:
7:00-8:00
B6-115 UH
OTN Event #
54052287
Complex Revascularization Rounds Presenters: CV Surgeons & Interventional Cardiologists
Faculty Supervisors: D. Nagpal & P. Garg
Case-based presentation and discussion
Learning Objectives:
1. To develop a systematic approach to interpretation of coronary angiograms.
2. To discuss interesting case examples and their management.
3. To apply an evidence-based approach to complex revascularization cases in order to improve outcomes.
2:00-5:00
2:00-3:00
B6-128 UH
B6-128 UH
DIDACTIC EDUCATION SESSIONS:
Cardiac rehabilitation: The concept and efficacy Presenter: K. Sidhu
Faculty Supervisor: N. Suskin
Learning Objectives:
1. To understand the components of a cardiac rehab program.
2. To be able to make an exercise prescription based on the risk classification of the patient.
3. Review the evidence behind the use of cardiac rehab in various disease states.
3:00-4:00
B6-128 UH
Non-atherosclerotic causes of myocardial infarction Presenter: V. Randhawa
Faculty Supervisor: G. Shoemaker
Learning Objectives:
1. To review definitions of non-atherosclerotic causes of MI.
2. To review the presentation and pathogenesis of non atherosclerotic causes of MI.
3. To review the management of non-atherosclerotic causes of MI.
4:00-5:00
B6-128 UH
ECHO: Prosthetic valve assessment
Learning Objectives:
Presenter: U. Manian Faculty Supervisor: B. Dias
1. Understand standard views of assessing prosthetic valves using echo.
2. Review main complications of prosthetic valves with echo examples.
3. Go through echo guidelines for prosthetic valves.
Wednesday, May 18:
8:00-9:00
12:00-1:00
1:00-4:00
B6-115 UH
EP Rounds: Device Rounds Presenters: Attendings & Fellows
Learning Objectives:
OTN Event #
54046782
1. To develop a systematic approach to device tracings.
2. To discuss interesting case examples.
3. To review programming features and troubleshooting.
B6-115 UH &
C2-504 VH
DSB1002
Western
Adult Congenital Cardiac Teaching Rounds - Videoconference from Toronto
Rounds Cancelled – to resume May 25th
PGME Academic Half Day – PARO Wellness Day
Thursday, May 19:
7:00-8:00
8:00-9:00
B6-115 UH &
B2-122 VH
Cardiac Cath/Interventional Rounds Presenter: K. Sridhar
Title of Presentation: To err is human, to check is …
Learning Objectives:
OTN Event #
47772162
1.
2.
3.
4.
B6-128 UH
Graphics Rounds: EST Presenter: N. Suskin
Discuss larger issue of safety in medicine.
Discuss some of the literature regarding effectiveness of safety checklists in surgery.
Discuss applicability to cardiac lab setting.
Discuss local initiative to incorporate safety checklist within LHSC cath lab.
Thursday, May 19:
6:30 pm
583 Eclipse Walk,
London
EP Journal Club Attendance open to Electrophysiologists and EP Fellows, Cardiology Residents and
EP Research Staff. RSVP to Charlene Grass (Ext. 33830 or email [email protected])
Topic: VT Ablation
Papers for Presentation:
1. Kiran Sidhu: Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy V.Y.
Reddy, et al. N Engl J Med 2007;357:2657-65
2. Usha Manian: Catheter ablation of stable ventricular tachycardia before defibrillator
implantation in patients with coronary heart disease (VTACH): a multicenter randomized
controlled trial K. Kuck, Lancet 2010;375-31-40
3. Tuan Nguyen: Freedom from recurrent ventricular tachycardia after catheter ablation is
associated with improved survival in patients with structural heart disease: An International VT
Ablation Center Collaborative Group study R. Tung, Heart Rhythm 2015;12:1997-2007.
4. Kevin Ng: Ablation or anti-arrhythmia Drugs for Ventricular Tachycardia: The VANISH trial
J. Sapp, et al. N Engl J Med 2016
Learning Objectives:
1. To systematically appraise and assimilate scientific evidence from journal articles and how it can be applied to
clinical practice and improvement in patient care.
2. To stay up to date with advances in biomedical and clinical evidence and to facilitate self-learning and
professional development.
3. To provide a forum for discussion and peer-review between health care professionals on current best practice that
is evidence based.
Friday, May 20:
8:00-9:00
B6-128 UH
EP Tracing Rounds: Case Presentations with ECG and Intra-cardiac tracings
Presenters: Attendings & Fellows
Learning Objectives:
1. To develop a systematic approach to EP tracings.
2. To discuss interesting case examples.
3. To review electrophysiology principles and concepts.
Some of these educational activities/rounds are an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal
College of Physicians and Surgeons of Canada, approved by the Division of Cardiology Education Committee - Western University.
Supported by unrestricted grants-in-aid provided by:
Aegerion Pharmaceuticals (Juxtapid (lomitapide)), Amgen Canada Inc. (Repatha), AstraZeneca Canada Inc. (Brilinta (Ticagrelor)), Bayer Inc. (XARELTO®
rivaroxaban tablet), Bristol-Myers Squibb Canada & Pfizer Canada Inc., (Eliquis (apixaban)), Medtronic of Canada Inc., Merck (Januvia, Janumet), Novartis
Pharmaceuticals Canada Inc. (Entresto), Servier Canada Inc. (Coversyl, Viacoram)